Outcome of board meeting of Krebs Biochemicals & Industries

Image
Capital Market
Last Updated : Dec 15 2014 | 10:34 PM IST

Held on 13 December 2014

Krebs Biochemicals & Industries announced that the Board of Directors of the Company at its meeting held on 13 December 2014, has considered the following;

1. The Board approved the resignation of R. Ch. Satyanarayana as Director w.e.f. 03 December 2014 who resigned due to his personal reasons.

2. The Board has decided to a) increase the Authorised Share Capital of the company from Rs. 10.00 crore to Rs.16.00 crore b) to amend the Memorandum of Association and Articles of Association of the company accordingly. It has been decided to seek the approval of the members by way of postal ballot. K. Jhansi Laxmi, practicing Company Secretary, Hyderabad was appointed as the scrutinizer for conducting the postal ballot process in a fair and transparent manner.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 15 2014 | 8:11 PM IST

Next Story